Registration Strip Icon for discussion Regístrate para interactuar en nuestros foros activos para discutir con inversores de ideas afines.

OSIP

Osi Pharmaceuticals (OSIP)

Osi Pharmaceuticals Inc. (MM)
Fecha:
Ordernar por:
 Showing the most relevant articles for your search:NASDAQ:OSIP
FechaHoraFuenteTítuloSímboloCompañía
09/06/201002:42PR Newswire (US)Astellas Completes Acquisition of OSI PharmaceuticalsNASDAQ:OSIPOsi Pharmaceuticals Inc. (MM)
08/06/201016:05Edgar (US Regulatory)(25-NSE)NASDAQ:OSIPOsi Pharmaceuticals Inc. (MM)
08/06/201014:17Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:OSIPOsi Pharmaceuticals Inc. (MM)
08/06/201012:09Edgar (US Regulatory)Amended tender offer statement by Third Party (SC TO-T/A)NASDAQ:OSIPOsi Pharmaceuticals Inc. (MM)
08/06/201002:42Dow Jones NewsAstellas Pharma: Successfully Completed Tender Offer For OSINASDAQ:OSIPOsi Pharmaceuticals Inc. (MM)
08/06/201002:09PR Newswire (US)Astellas Announces Successful Completion of Tender Offer for Shares of OSINASDAQ:OSIPOsi Pharmaceuticals Inc. (MM)
07/06/201015:31Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:OSIPOsi Pharmaceuticals Inc. (MM)
04/06/201009:49Business WireOSI Pharmaceuticals Announces Occurrence of a Fundamental Change for Convertible NotesNASDAQ:OSIPOsi Pharmaceuticals Inc. (MM)
03/06/201002:40Dow Jones NewsAstellas Pharma: Tender Offer For OSI SuccessfulNASDAQ:OSIPOsi Pharmaceuticals Inc. (MM)
03/06/201002:08PR Newswire (US)Astellas Announces Successful Completion of Initial Tender Offer for Shares of OSI and Announces Subsequent Offer PeriodNASDAQ:OSIPOsi Pharmaceuticals Inc. (MM)
28/05/201010:25Edgar (US Regulatory)Statement of Beneficial Ownership (SC 13D)NASDAQ:OSIPOsi Pharmaceuticals Inc. (MM)
27/05/201012:40Edgar (US Regulatory)Amended Statement of Ownership: Solicitation (SC 14D9/A)NASDAQ:OSIPOsi Pharmaceuticals Inc. (MM)
26/05/201016:42PR Newswire (US)Standard & Poor's Announces Changes to U.S. IndicesNASDAQ:OSIPOsi Pharmaceuticals Inc. (MM)
26/05/201005:04Edgar (US Regulatory)Amended Statement of Beneficial Ownership (SC 13D/A)NASDAQ:OSIPOsi Pharmaceuticals Inc. (MM)
17/05/201013:54Edgar (US Regulatory)Current report filing (8-K)NASDAQ:OSIPOsi Pharmaceuticals Inc. (MM)
17/05/201012:11PR Newswire (US)Expiration Date of OSI Offer Extended to June 2, 2010NASDAQ:OSIPOsi Pharmaceuticals Inc. (MM)
17/05/201009:17Dow Jones NewsMARKET SNAPSHOT: U.S. Stocks Straddle Flat Line, Boosted By Lowe'sNASDAQ:OSIPOsi Pharmaceuticals Inc. (MM)
16/05/201020:13Dow Jones NewsAstellas: Agreed To Buy OSI Pharmaceuticals For $4 BillionNASDAQ:OSIPOsi Pharmaceuticals Inc. (MM)
16/05/201019:20PR Newswire (US)Astellas Pharma Inc. to Acquire OSI Pharmaceuticals, Inc.NASDAQ:OSIPOsi Pharmaceuticals Inc. (MM)
10/05/201014:44Edgar (US Regulatory)Amended Statement of Ownership (SC 13G/A)NASDAQ:OSIPOsi Pharmaceuticals Inc. (MM)
30/04/201015:23Edgar (US Regulatory)Amended Annual Report (10-K/A)NASDAQ:OSIPOsi Pharmaceuticals Inc. (MM)
29/04/201004:50Dow Jones NewsRoche Diabetes Drug Taspoglutide Shows Promising Test ResultsNASDAQ:OSIPOsi Pharmaceuticals Inc. (MM)
29/04/201000:15Business WireOSI Pharmaceuticals Announces That Tarceva® Received Approval in the European Union for Maintenance Use in Advanced Non-Smal...NASDAQ:OSIPOsi Pharmaceuticals Inc. (MM)
26/04/201007:00Business WireOSI Pharmaceuticals Announces That “RADIANT”, an International Phase III Tarceva Adjuvant Trial in Non-Small Cell Lung Ca...NASDAQ:OSIPOsi Pharmaceuticals Inc. (MM)
23/04/201013:02Edgar (US Regulatory)Additional Proxy Soliciting Materials - Non-Management (definitive) (DFAN14A)NASDAQ:OSIPOsi Pharmaceuticals Inc. (MM)
23/04/201003:44PR Newswire (US)Expiration Date of OSI Offer Extended to May 17, 2010NASDAQ:OSIPOsi Pharmaceuticals Inc. (MM)
23/04/201003:34Dow Jones NewsAstellas: Extending Tender Offer For OSI To May 17NASDAQ:OSIPOsi Pharmaceuticals Inc. (MM)
22/04/201015:05Business WireOSI Pharmaceuticals, Inc. Announces First Quarter 2010 Financial ResultsNASDAQ:OSIPOsi Pharmaceuticals Inc. (MM)
16/04/201019:35Business WireFDA Approves Tarceva as a Maintenance Therapy for Advanced Non-Small Cell Lung CancerNASDAQ:OSIPOsi Pharmaceuticals Inc. (MM)
14/04/201009:00Business WireOSI Pharmaceuticals to Announce First Quarter 2010 Financial Results on April 22, 2010NASDAQ:OSIPOsi Pharmaceuticals Inc. (MM)
 Showing the most relevant articles for your search:NASDAQ:OSIP